-+ 0.00%
-+ 0.00%
-+ 0.00%

UPSTREAM BIO PRESENTS NEW DATA FROM PHASE 2 VIBRANT TRIAL OF VEREKITUG DEMONSTRATING IMPROVEMENT IN ASTHMA SYMPTOM CONTROL IN PARTICIPANTS WITH CRSWNP AND COMORBID ASTHMA AT THE ATS 2026 INTERNATIONAL CONFERENCE

Reuters·05/18/2026 15:30:00

Please log in to view news